Colombia vs Iran: Cause of death, by non-communicable diseases, ages 5-14, male
Colombia
38.3%
in 2021
Iran
39.3%
in 2021
Colombia rank
80th
Iran rank
78th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Colombia
- Iran
How they compare
Iran currently reports 39.3% against 38.3% in Colombia, a difference of 1.0%.
Across all 6 years both countries report, Iran has been ahead every year.
Colombia ranks 80th and Iran ranks 78th of 185 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.4% | 34.0% | 8.6% | Iran |
| 2010s | 32.3% | 40.6% | 8.3% | Iran |
| 2020s | 40.0% | 42.2% | 2.2% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Colombia or Iran?
- Iran, at 39.3% against 38.3% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Colombia and Iran?
- 1.0%, with Iran ahead.
- How many years of comparable data are there for Colombia and Iran?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Iran rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Colombia ranks 80th and Iran ranks 78th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.